- Home
- INUV vs AEON Comparison
INUV vs AEON Comparison
Compare INUV & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INUV | AEON |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | 8 |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 25.8M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | INUV | AEON |
|---|---|---|
| Price | $1.60 | $0.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $11.00 | $7.20 |
| AVG Volume (30 Days) | ★ 184.2K | 64.9K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $86,209,305.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.89 | N/A |
| P/E Ratio | $12.85 | ★ N/A |
| Revenue Growth | ★ 2.88 | N/A |
| 52 Week Low | $0.36 | $0.53 |
| 52 Week High | $6.27 | $1.45 |
Technical Indicators
Market Signals| Indicator | INUV | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 42.06 | 37.67 |
| Support Level | $1.31 | $0.70 |
| Resistance Level | $2.01 | $0.83 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 41.09 | 25.36 |
Price Performance
Historical ComparisonAbout INUV Inuvo Inc.
Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.